DEC 19, 2018 5:50 PM PST

Promising Drug for ALS?

WRITTEN BY: Nouran Amin

ALS, standing for amyotrophic lateral sclerosis, also known as Lou Gehrig's disease, is a progressive neurodegenerative disease affecting the nerve cells of the brain and the spinal cord. Current treatments for ALS work by slowing the progression of the disease however by only a few months. Now, research at the University of Alberta shows a promising drug that not only significantly slows the progression of the disease but can revolutionize treatment for ALS patients by extending and improving their quality of life.

Learn more about ALS:

The drug is called telbivudine and is used as a treatment for patients with hepatitis making it particularly safe as a promising therapeutic for ALS. "It is already proven safe to use in patients, and it has very good potential for repurposing to use in a new clinical setting against ALS," said Ted Allison, co-author of the study and associate professor in the Department of Biological Sciences.

In the research study published in Neurobiology of Disease, telbivudine was selected using computer simulations of most likely drug candidates before being tested on animal models. Specifically, the works by targeting a protein called SOD1. The protein was found to misfold and function improperly in ALS producing toxic effects that characterizes much of the phenotypic symptoms of the disease.

Credit: Medical News Today

"SOD1 is a protein that is known to misfold and misbehave in most cases of patients with ALS," says Allison. "We showed that telbivudine can greatly reduce the toxic properties of SOD1, including improving the health of the subject's motor neurons and improving movement."

However, because ALS is still not well understood by researchers and clinicians—promising therapeutics may take a while before being sent to clinical trials. But, this study provides one step closer.

“We don't yet know exactly what goes wrong first in the motor neurons or how the misbehaving SOD1 causes toxicity. Because there is still much to learn about the disease, the ALS research community focuses on both understanding ALS and on developing promising therapies,” explains lead author of the study—Michele DuVal.

Source: University of Alberta

About the Author
  • Nouran earned her BS and MS in Biology at IUPUI and currently shares her love of science by teaching. She enjoys writing on various topics as well including science & medicine, global health, and conservation biology. She hopes through her writing she can make science more engaging and communicable to the general public.
You May Also Like
JUN 13, 2020
Cannabis Sciences
CBD Kills Brain Cancer Cells in Petri Dish
JUN 13, 2020
CBD Kills Brain Cancer Cells in Petri Dish
Cannabis products are not only popular for their psychoactive effects. An increasing number of companies and researchers ...
JUN 14, 2020
Cell & Molecular Biology
A Fungal Compound That Triggers Self-Destruction in Cancer Cells
JUN 14, 2020
A Fungal Compound That Triggers Self-Destruction in Cancer Cells
To describe it in a very basic way, cancer is uncontrolled cell growth. A number of processes regulate various aspects o ...
JUL 04, 2020
Cardiology
Discovering a New Signal Junction Controlling Pulmonary Arterial Hypertension
JUL 04, 2020
Discovering a New Signal Junction Controlling Pulmonary Arterial Hypertension
Pulmonary Arterial Hypertension (PAH) is a progressive and fatal disease characterized by the muscularization of blood c ...
JUL 15, 2020
Microbiology
A Common Drug Could Help Reduce the Risk of COVID-19 Infections
JUL 15, 2020
A Common Drug Could Help Reduce the Risk of COVID-19 Infections
Heparin is a very common drug that's been approved as an anticoagulant since 1992. Researchers have now found that the m ...
JUL 19, 2020
Drug Discovery & Development
Synapse-Saving Proteins Could Stave Off Alzheimer's
JUL 19, 2020
Synapse-Saving Proteins Could Stave Off Alzheimer's
Researchers at the University of Texas have identified a new subset of proteins capable of protecting synapses- the stru ...
JUL 30, 2020
Cannabis Sciences
CBD Makes Antibiotics More Effective
JUL 30, 2020
CBD Makes Antibiotics More Effective
Researchers from the University of Southern Denmark have found that cannabidiol (CBD) combined with antibiotics has a mo ...
Loading Comments...